Xilio Therapeutics share price logo

Xilio Therapeutics

NASDAQ: XLO

$8.07

-0.17

(-2.00%)

as on

Xilio Therapeutics Stock Performance

as on November 14, 2026 at 2:16 pm IST

  • Day's Low

    $7.80
    $8.07
    downward going graph

    3.35%

    Downside

  • 52 Week's Low

    52 Week's High

    $6.47
    $11.30
    downward going graph

    19.89%

    Downside

    40.00%

    Upside

    downward going graph

Xilio Therapeutics share price movements today

Previous Close
$8.24
Open
$7.94
Volume
246.2K
Market Cap
$56.2M
Day's Low - High
$7.80 - $8.07
52 Week Low - High
$6.47 - $11.30

Xilio Therapeutics Historical Returns

1 Month Return
-9.27 %
3 Month Return
-11.94 %
1 Year Return
-18.44 %
3 Year Return
-55.97 %
5 Year Return
-97.4 %

Xilio Therapeutics Stock Fundamentals & Key Indicators

Check Xilio Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$56.2M

EPS (TTM)

-0.25

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-32.6

Industry PE ratio

-2.26

PEG Ratio

-0.08

EBITDA

-10.2M

Revenue (TTM)

55.0M

Profit Margin

99.37%

Return On Equity TTM

-18.51%

Xilio Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xilio Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$56.2M-97.40%-32.6099.37%0.00%
Neutral$100.6B0.07%-35.1828.00%0.00%
StrongBuy$47.5BNA68.7388.39%0.00%
StrongBuy$137.6B187.58%34.7885.57%0.00%
Buy$99.2B51.37%20.2985.77%0.39%

Stock Returns calculator for Xilio Therapeutics Stock including INR - Dollar returns

The Xilio Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Xilio Therapeutics investment value today

Current value as on today

₹86,610

Returns

-₹13,390

(-13.39%)

Returns from Xilio Therapeutics Stock

-₹18,491 (-18.49%)

Dollar Impact

₹5,102 (+5.1%)

Analyst Recommendation on Xilio Therapeutics Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Xilio Therapeutics. Average target price of $18

Xilio Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Xilio Therapeutics.

What analysts predicted

55.17%UPSIDE

Target Price

$18

Current Price

$8.07

Analyzed by

7 Analysts

Target

$18.00

Xilio Therapeutics target price $18, a slight upside of 55.17% compared to current price of $8.07. According to 7 analysts rating.

Indian Investors' Interest in Xilio Therapeutics Stock

Search interest for Xilio Therapeutics Stock has increased by 21% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:21% versus previous 30 day period

Xilio Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
2
2
1
2
8
19
13
12
18
9
Gross Profit
2
2
1
2
-7
19
13
12
18
9
Operating Income
-14
-14
-13
-13
-14
-1
-11
-14
-3
-11
EBITDA
-14
-14
-12
-12
-15
-15
10
-9
-6
-5
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-13
-14
-13
-13
-15
-16
10
-9
-6
-5
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-13
-14
-13
-13
-15
-16
10
-9
-6
-5
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
-89.63%
100.00%
100.00%
97.28%
100.00%
100.00%

Xilio Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
6
43
Gross Profit
0
-1
-1
-
-
6
42
Operating Income
-19
-54
-75
-89
-79
-60
-41
EBITDA
-17
-53
-73
-86
-74
-58
-33
Interest Expense
-
0
0
-
-
0
-
Depreciation
0
1
1
1
1
1
1
Income Before Tax
-17
-55
-75
-88
-76
-58
-35
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-17
-55
-75
-88
-76
-58
-35
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
96.48%

Xilio Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
-13
-14
-13
-13
-15
-16
10
-9
-6
-5
Operating Cash Flow
19
-13
-14
28
-14
-17
-1
-22
-18
-13
Investing Cash Flow
0
0
0
0
0
-
0
0
0
0
Financing Cash Flow
20
0
8
4
47
0
35
35
4
-
Change in Cash
39
-13
-5
33
32
-17
33
12
-14
-13

Xilio Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-17
-55
-75
-88
-76
-58
-35
Operating Cash Flow
-17
-36
-80
-75
-68
-18
-4
Investing Cash Flow
0
-2
-1
-1
0
0
0
Financing Cash Flow
60
10
260
0
-6
29
87
Change in Cash
41
-28
178
-77
-75
10
82

Global Institutional Holdings in Xilio Therapeutics

Check out the Institutions with significant holdings in Xilio Therapeutics.

Funds
Holdings
Russo Rene
4.95%
Vanguard
3.00%
VANGUARD INDEX FUNDS
2.71%
Fidelity Concord Street Trust
0.53%
Luptakova Katarina
0.51%

Xilio Therapeutics News & Key Events

  • img

    Today's Timeline - 30 October

    Fri, 09:00 PM

    -

    Xilio Therapeutics resumes trading after volatility pause; doses first patient in XTX501 trial.

Insights on Xilio Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 201.4% return, outperforming this stock by 257.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 801.8% return, outperforming this stock by 820.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, XLO stock has moved down by -6.3%

About Xilio Therapeutics

Xilio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to crafting immunotherapies aimed at strengthening the immune systems of cancer patients. A key part of their pipeline is XTX101, a tumor-selective anti-CTLA-4 monoclonal antibody that is currently undergoing Phase 1/2 clinical trials for various solid tumors. The company also develops a range of cytokine programs, including XTX202 (a modified IL-2), XTX301 (an IL-12 product candidate), and XTX401 (an IL-15 product candidate). These cytokine therapies are ingeniously engineered with a protein domain that keeps them inactive until proteases specific to the tumor microenvironment (TME) cleave this mask, thereby initiating their therapeutic activity. Xilio Therapeutics, Inc. was founded in 2016 and is based in Waltham, Massachusetts.
OrganisationXilio Therapeutics
Headquarters828 Winter Street, Waltham, MA, 02451, US
IndustryBiotechnology
CEORene Russo

Key Management of Xilio Therapeutics

Name

Title

Dr. Uli Bialucha Ph.D.

Chief Scientific Officer

Mr. Benjamin S. Harshbarger J.D.

Chief Legal Officer

Dr. Yariv Houvras M.D., Ph.D.

Chief Medical Officer

Dr. Rene Russo BCPS, Pharm.D.

President, CEO & Director

Mr. Christopher Frankenfield

CFO & COO

Dr. Scott Coleman Ph.D.

Chief Development Officer

Ms. Ruth du Moulin

Senior Vice President of Medical Affairs

Mr. Kevin M. Brennan

Senior Vice President of Finance & Accounting

Mr. Nathan McBride

Chief Information Officer

FAQs

What is Xilio Therapeutics share price today?

Xilio Therapeutics share price today is $8.07 as on at the close of the market. Xilio Therapeutics share today touched a day high of $8.07 and a low of $7.80.

What is the 52 week high and 52 week low for Xilio Therapeutics share?

Xilio Therapeutics share touched a 52 week high of $11.30 on and a 52 week low of $6.47 on . Xilio Therapeutics stock price today i.e. is closed at $8.07,which is 28.57% down from its 52 week high and 24.82% up from its 52 week low.

What is Xilio Therapeutics's market capitalisation today?

Xilio Therapeutics market capitalisation is $0.00T as on .

How to invest in Xilio Therapeutics Stock (XLO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xilio Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Xilio Therapeutics Stock (XLO) from India?

Indian investors can start investing in Xilio Therapeutics (XLO) shares with as little as ₹94.23999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Xilio Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Xilio Therapeutics share’s latest price of $8.07 as on November 14, 2026 at 8:46 am IST, you will get 1.2392 shares of Xilio Therapeutics. Learn more about fractional shares .

What are the returns that Xilio Therapeutics has given to Indian investors in the last 5 years?

Xilio Therapeutics stock has given -97.4% share price returns and 25.93% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?